Mylan sells Biocon

Mylan to sell up to $363 million stake in India's Biocon, term sheet shows

Mylan Inc plans to sell up to 92 million shares in Indian drugmaker Biocon Ltd, valued at up to $363 million, according to a term sheet reviewed by Reuters.